335 filings
Page 2 of 17
SC 14D9/A
bfh86v99g1kbdo3em4l
22 Apr 21
Tender offer solicitation (amended)
9:13am
SC 14D9/A
30ns 53vq35
13 Apr 21
Tender offer solicitation (amended)
8:05am
SC TO-T/A
s9kugfr
13 Apr 21
Third party tender offer statement (amended)
7:07am
SC 14D9/A
jixe7sw ga
7 Apr 21
Tender offer solicitation (amended)
12:00am
SC TO-T/A
3uuwa6d99m7kcva7zu1u
6 Apr 21
Third party tender offer statement (amended)
5:28pm
SC 14D9
hcood2ebwpaku3s
25 Mar 21
Tender offer solicitation
7:06am
SC TO-T
2uhhz39
25 Mar 21
Third party tender offer statement
7:02am
SC TO-C
aez6faud6bggoo
18 Mar 21
Information about tender offer
5:19pm
SC TO-C
cu9qs7j
17 Mar 21
Information about tender offer
4:56pm
SC TO-C
bborx1 xhle8
15 Mar 21
Information about tender offer
5:11pm
SC14D9C
ech wksc933a3xhx
15 Mar 21
Written communication relating to third party tender offer
5:04pm
8-K
jritkvi9u er19h56
15 Mar 21
Entry into a Material Definitive Agreement
5:01pm
SC14D9C
lqzojk1xz6gcbqdavt2k
15 Mar 21
Written communication relating to third party tender offer
9:17am
SC14D9C
keg3j0g
15 Mar 21
Written communication relating to third party tender offer
9:15am
8-K
c8lxkwp a8yq3
15 Mar 21
Roche to acquire GenMark Diagnostics for US$ 24.05 per share with the expectation to close in the 2nd quarter of 2021
9:12am
SC TO-C
002v4 uoue5
15 Mar 21
Information about tender offer
7:01am
8-K
bidznev6hzoufyg5mj
25 Feb 21
GenMark Diagnostics Reports Fourth Quarter and Full Year 2020 Results
4:08pm
8-K
36nzilyhpk9i7x7bmzz8
24 Feb 21
Departure of Directors or Certain Officers
4:31pm
8-K
br6fea
11 Jan 21
GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2020
4:11pm